Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph⁺ALL)WASSMANN, Barbara; PFEIFER, Heike; GANSER, Arnold et al.Blood. 2006, Vol 108, Num 5, pp 1469-1477, issn 0006-4971, 9 p.Article

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyFEDERMANN, Birgit; BORNHAUSER, Martin; FAUL, Christoph et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1523-1531, issn 0390-6078, 9 p.Article

Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3―Specific Tyrosine Kinase Inhibitor in t(4;14) MyelomaBISPING, Guido; WENNING, Doris; VOLPERT, Sarah et al.Clinical cancer research (Print). 2009, Vol 15, Num 2, pp 520-531, issn 1078-0432, 12 p.Article

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti―T-cell globulin ATG-FreseniusSOCIE, Gérard; SCHMOOR, Claudia; KOLBE, Karin et al.Blood. 2011, Vol 117, Num 23, pp 6375-6382, issn 0006-4971, 8 p.Article

Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphomaGÖKBUGET, Nicola; HARTOG, Christina-Maria; JUNGHANSS, Christian et al.Haematologica (Roma). 2011, Vol 96, Num 2, pp 238-244, issn 0390-6078, 7 p.Article

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trialRUUTU, Tapani; VOLIN, Liisa; BLAU, Igor W et al.Haematologica (Roma). 2011, Vol 96, Num 9, pp 1344-1350, issn 0390-6078, 7 p.Article

Clinical molecular imaging in intestinal graft-versus-host disease : mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomographySTELLJES, Matthias; HERMANN, Sven; BREMER, Christoph et al.Blood. 2008, Vol 111, Num 5, pp 2909-2918, issn 0006-4971, 10 p.Article

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs AnalysisSTELLJES, Matthias; KRUG, Utz; BERNING, Björna et al.Journal of clinical oncology. 2014, Vol 32, Num 4, pp 288-296, issn 0732-183X, 9 p.Article

Non-invasive ventilation in immunosuppressed patients with pneumonia and extrapulmonary sepsisRAZLAF, Peter; PABST, Dirk; MOHR, Michael et al.Respiratory medicine. 2012, Vol 106, Num 11, pp 1509-1516, issn 0954-6111, 8 p.Article

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALLTOPP, Max S; GÖKBUGET, Nicola; STELLJES, Matthias et al.Blood. 2012, Vol 120, Num 26, pp 5185-5187, issn 0006-4971, 3 p.Article

Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effectsSTELLJES, Matthias; SPECHT, Christiane; SILLING, Gerda et al.Transplantation. 2007, Vol 83, Num 3, pp 314-322, issn 0041-1337, 9 p.Article

Imatinib compared with chemotherapy as front-line treatment of elderly patients with philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)OTTMANN, Oliver G; WASSMANN, Barbara; PFEIFER, Heike et al.Cancer. 2007, Vol 109, Num 10, pp 2068-2076, issn 0008-543X, 9 p.Article

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantationGÖKBUGET, Nicola; STANZE, Daniel; SCHAICH, Markus et al.Blood. 2012, Vol 120, Num 10, pp 2032-2041, issn 0006-4971, 10 p.Article

Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 studyBETHGE, Wolfgang A; LANGE, Thoralf; WULF, Gerald et al.Blood. 2010, Vol 116, Num 10, pp 1795-1802, issn 0006-4971, 8 p.Article

Mode-of-Action, Efficacy, and Safety of a Homologous Multi-Epitope Vaccine in a Murine Model for Adjuvant Treatment of Renal Cell Carcinoma. CommentaryDOEHN, Christian; ESSER, Norbert; PAUELS, Hans-Gerd et al.European urology. 2009, Vol 56, Num 1, pp 123-133, issn 0302-2838, 11 p.Article

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphomaKORFEL, Agnieszka; MARTUS, Peter; FISCHER, Lars et al.British journal of haematology. 2005, Vol 128, Num 2, pp 177-183, issn 0007-1048, 7 p.Article

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaSTELLJES, Matthias; BORNHAUSER, Martin; NEUBAUER, Andreas et al.Blood. 2005, Vol 106, Num 9, pp 3314-3321, issn 0006-4971, 8 p.Article

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph⁺ALL) treated with imatinibWASSMANN, Barbara; PFEIFER, Heike; SCHWERDTFEGER, Rainer et al.Blood. 2004, Vol 103, Num 4, pp 1495-1498, issn 0006-4971, 4 p.Article

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell―engaging CD19/CD3-bispecific BiTE antibody blinatumomabKLINGER, Matthias; BRANDL, Christian; STELLJES, Matthias et al.Blood. 2012, Vol 119, Num 26, pp 6226-6233, issn 0006-4971, 8 p.Article

High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantationGÖKBUGET, Nicola; BASARA, Nadezda; KOBBE, Guido et al.Blood. 2011, Vol 118, Num 13, pp 3504-3511, issn 0006-4971, 8 p.Article

Targeted Therapy With the T-Cell―Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free SurvivalTOPP, Max S; KUFER, Peter; STELLJES, Matthias et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2493-2498, issn 0732-183X, 6 p.Article

Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia : A Report From the Cooperative German Transplant Study GroupSCHETELIG, Johannes; BORNHDUSER, Martin; WIEDEMANN, Barbel et al.Journal of clinical oncology. 2008, Vol 26, Num 32, pp 5183-5191, issn 0732-183X, 9 p.Article

Early molecular response to posttransplantation imatinib determines outcome in MRD⁺ philadelphia-positive acute lymphoblastic leukemia (Ph⁺ ALL)WASSMANN, Barbara; PFEIFER, Heike; PERZ, Jolanta et al.Blood. 2005, Vol 106, Num 2, pp 458-463, issn 0006-4971, 6 p.Article

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8⁺ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targetsSTELLJES, Matthias; STROTHOTTE, Robert; OELMANN, Elisabeth et al.Blood. 2004, Vol 104, Num 4, pp 1210-1216, issn 0006-4971, 7 p.Article